Reza Shojaei Asks: What if Your Country Could Stop Depending on Imported Plasma Medicines, Permanently?
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
“What if your country could stop depending on imported plasma medicines, permanently?
For decades, most nations accepted plasma dependency as inevitable. Today, one country has proven that assumption wrong.
Egypt is now one of only a few countries in the world to achieve full national self-sufficiency in essential plasma-derived medicines, including IVIG, albumin, and hemophilia clotting factors. And it didn’t take 50 years to execute once the strategy was right; it took just five.
This transformation was not accidental. It was built through:
- Presidential-level political commitment
- A first-of-its-kind public–private joint venture
- FDA-aligned regulation
- Compensated, medically monitored donors
- And full vein-to-vial industrial integration
In this edition of Blood and Plasma Pulse, we unpack Egypt’s 50-year journey from early failed fractionation attempts to becoming Africa’s first plasma manufacturing hub, and what policymakers, regulators, and health system leaders around the world can learn from it, right now.
If your country is facing:
- IVIG shortages
- Rising plasma medicine costs
- Import dependency
- Or national biologics insecurity
This is not a story you can afford to ignore.”

Read full paper here.
Read more from Reza Shojaei on Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers